Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole Or Fluconazole Therapy, For Treatment Of Documented Candidemia/Invasive Candidiasis In Intensive Care Unit Patient Populations

NCT00689338 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00689338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00689338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole Or Fluconazole Therapy, For Treatment Of Documented Candidemia/Invasive Candidiasis In Intensive Care Unit Patient Populations
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
May 31, 2010
Enrollment
216 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

invasive candidiasis